Resultados de la búsqueda 11-20 of 18835 for Kidney failure

1. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   A Study to Promote Shared Decision Making of Treatment Choices in Patients who have Advanced Kidney Disease. Rochester, Minn., Scottsdale/Phoenix, Ariz ...

2. Transplant Center de Mayo Clinic - Ensayos clínicos

   ... kidney disease. APOLLO will test DNA from kidney donors and recipients of kidney transplants for APOL1 to determine effects on kidney transplant-related ...

3. Transplant Center de Mayo Clinic - Ensayos clínicos

   ... kidney disease. APOLLO will test DNA from kidney donors and recipients of kidney transplants for APOL1 to determine effects on kidney transplant-related ...

4. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to analyze the effect of parity, menopause and reproductive lifespan on kidney structure and function. 24-Hydroxylase Deficiency ...

5. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

6. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

7. Nefropatía crónica - Síntomas y causas - Mayo Clinic

   ... disorders/chronic-kidney-disease/chronic-kidney-disease. Accessed June 25, 2025. Ferri FF. Chronic kidney disease. In: Ferri's Clinical Advisor 2025 ...

8. Radiología - Ensayos clínicos - Mayo Clinic

   ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

9. Radiología - Ensayos clínicos - Mayo Clinic

   ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

10. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the impact of palliative care consultations on quality of life and advance care planning in end-stage renal disease ...